We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MOR market cap is 694.11M. The company's latest EPS is EUR -5.0460 and P/E is -14.15.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 62.32M | 53.17M | 63.78M | 59.02M | 27.54M |
| Operating Income | -71.72M | -52.29M | -51.95M | -83.72M | -265.46M |
| Net Income | -44.43M | -73.97M | -119.6M | 48.27M | -311.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 71.76M | 327.7M | 179.61M | 278.27M | 238.28M |
| Operating Income | -107.74M | 18.29M | -508.22M | -225.03M | -259.68M |
| Net Income | -103.01M | 97.89M | -514.46M | -151.06M | -189.73M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 2.23B | 2.14B | 2.1B | 2.03B | 1.83B |
| Total Liabilities | 2.13B | 2.11B | 2.17B | 1.98B | 2.09B |
| Total Equity | 97.03M | 31.67M | -66.97M | 49.05M | -261.67M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 496.44M | 1.66B | 2.56B | 2.4B | 2.03B |
| Total Liabilities | 101.74M | 1.04B | 2.31B | 2.24B | 1.98B |
| Total Equity | 394.7M | 621.32M | 244.88M | 157.41M | 49.05M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -71.24M | -197.2M | -235.84M | -295.84M | -67.61M |
| Investing | 9.88M | 33.13M | 72.51M | 15.37M | 28.62M |
| Financing | -45.32M | -50M | -51.21M | 43M | -950k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -80.14M | 35.27M | -481.45M | -366.71M | -295.84M |
| Investing | 78.55M | -879.62M | -831.01M | 345M | 15.37M |
| Financing | 353k | 907.19M | 1.32B | 311.42M | 43M |
| Market Cap | 694.11M |
| Price to Earnings Ratio | -14.15 |
| Price to Sales Ratio | 11.26 |
| Price to Cash Ratio | 16.93 |
| Price to Book Ratio | 54.72 |
| Dividend Yield | - |
| Shares Outstanding | 37.6M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.72 (3.81%) |
| Company Name | MorphoSys AG |
| Address |
lena-christ-str. 48 munich 82152 |
| Website | https://www.morphosys.com |
| Industry | pharmaceutical biolog/vaccines (H23) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
